Evidence map›Paper›PMID 24841197›Full record

ArticleThe Journal of biological chemistry2014

Sialyl-lactotetra, a novel cell surface marker of undifferentiated human pluripotent stem cells.

Angela Barone, Karin Säljö, John Benktander, Maria Blomqvist, Jan-Eric Månsson, Bengt R Johansson, Johan Mölne, Anders Aspegren, Petter Björquist, Michael E Breimer and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Glycan Markers of Pluripotent Stem Cells.Advances in experimental medicine and biology · 2026
    Review
  4. Virulence · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Angela BaroneFrom the Institute of Clinical Sciences, Department of Surgery, S-41 345 Göteborg, Sweden.
Karin SäljöFrom the Institute of Clinical Sciences, Department of Surgery, S-41 345 Göteborg, Sweden.
John Benktanderthe Institute of Biomedicine, Department of Medical Biochemistry and Cell Biology, S-40530 Göteborg, Sweden.
Maria Blomqvistthe Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine, S-413 45 Göteborg, Sweden.
Jan-Eric Månssonthe Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine, S-413 45 Göteborg, Sweden.
Bengt R Johanssonthe Institute of Biomedicine, Department of Medical Biochemistry and Cell Biology, S-40530 Göteborg, Sweden.
Johan Mölnethe Institute of Biomedicine, Department of Pathology, S-413 45 Göteborg, Sweden, and.
Anders Aspegrenthe Cellectis Stem Cells, Cellartis AB, S-413 46 Göteborg, Sweden.
Petter Björquistthe Cellectis Stem Cells, Cellartis AB, S-413 46 Göteborg, Sweden.
Michael E BreimerFrom the Institute of Clinical Sciences, Department of Surgery, S-41 345 Göteborg, Sweden, michael.breimer@clinchem.gu.se.
Susann Tenebergthe Institute of Biomedicine, Department of Medical Biochemistry and Cell Biology, S-40530 Göteborg, Sweden, Susann.Teneberg@medkem.gu.se.
University of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell surface glycoconjugates are used as markers for undifferentiated pluripotent stem cells. Here, antibody binding and mass spectrometry characterization of acid glycosphingolipids isolated from a large number (1 × 10(9) cells) of human embryonic stem cell (hESC) lines allowed identification of several novel acid glycosphingolipids, like the gangliosides sialyl-lactotetraosylceramide and sialyl-globotetraosylceramide, and the sulfated glycosphingolipids sulfatide, sulf-lactosylceramide, and sulf-globopentaosylceramide. A high cell surface expression of sialyl-lactotetra on hESC and human induced pluripotent stem cells (hiPSC) was demonstrated by flow cytometry, immunohistochemistry, and electron microscopy, whereas sulfated glycosphingolipids were only found in intracellular compartments. Immunohistochemistry showed distinct cell surface anti-sialyl-lactotetra staining on all seven hESC lines and three hiPSC lines analyzed, whereas no staining of hESC-derived hepatocyte-like or cardiomyocyte-like cells was obtained. Upon differentiation of hiPSC into hepatocyte-like cells, the sialyl-lactotetra epitope was rapidly down-regulated and not detectable after 14 days. These findings identify sialyl-lactotetra as a promising marker of undifferentiated human pluripotent stem cells.

Indexed as

Cell DifferentiationAcidic GlycosphingolipidsBiomarkersCarbohydrate SequenceCell LineDown-RegulationEmbryonic Stem CellsEpitopesFlow CytometryGangliosidesHumansInduced Pluripotent Stem CellsMass SpectrometryPluripotent Stem CellsAcidic GlycosphingolipidsBiomarkersEpitopesGangliosidessialyl-lactotetraosylceramideCarbohydrate StructureCell Surface Immune RecognitionEmbryonic Stem CellGangliosidesGlycobiologyGlycolipid StructureMass Spectrometry (MS)Sialyl-lactotetraosylceramideSulfatide

Identifiers

PMID24841197
PMCPMC4081926
OpenAlexW1967727763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.